Researcher wins GAP award to propel work from lab to marketplace

Pradeep Bhide, director of the Center for Brain Repair at the FSU College of Medicine, is developing a new, non-stimulant drug to treat cognitive inflexibility. Cognitive inflexibility hampers a child’s ability to learn by making it difficult to switch between thinking about one concept to another or multiple concepts simultaneously. Aspects of cognitive inflexibility are found in autism, obsessive compulsive disorder, schizophrenia and attention deficit hyperactive disorder. It affects roughly 25 million people, but no drug has been developed specifically to treat this condition.